Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Johnson & Johnson Forecast Fiscal Year 2024 Operational Sales Of $88.7B-$89.1B Versus Prior Guidance Of $88.2B–$89.0B And Consensus $88.43B

Author: Benzinga Newsdesk | April 16, 2024 06:28am

Posted In: JNJ